Related Experiment Video
Updated: Jul 18, 2025
08:00
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
18.1K
Off to boarding school: Exploring how physicians learn in Tumor Board
1Division of Pediatric Hematology/Oncology/BMT, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Pediatric Blood & Cancer
|August 23, 2023
Summary
Physicians learn in multidisciplinary Tumor Boards (TB) through collaboration and teaching each other. Optimizing these interactions can enhance the educational value of TB for all participants.
Area of Science:
- Oncology
- Medical Education
- Qualitative Research
Background:
- Tumor Boards (TB) are required multidisciplinary conferences in oncology.
- Evidence supports TB's role in clinical decision-making and perceived learning value.
- Limited data exist on how physicians learn within the TB setting.
Purpose of the Study:
- To explore the learning experiences of physician participants in Tumor Boards.
- To identify factors influencing physician learning during multidisciplinary cancer case conferences.
Main Methods:
- An exploratory, qualitative study using naturalistic inquiry.
- Semi-structured interviews were conducted with 15 purposefully sampled physician participants.
- Interview data were transcribed and analyzed to identify emergent themes.
Main Results:
- Mutual educational goals among stakeholders enhance learning.
- Presenting cases is crucial for trainee learning.
- Discussion and collaboration during presentations facilitate learning for attendees.
- Participants actively cultivate a shared learning environment.
- Virtual TB formats can impact participant engagement and learning.
Conclusions:
- Learning in TB aligns with the cognitive apprenticeship model.
- Identifying learning facilitators and inhibitors can optimize the educational process.
- TB exemplifies the social nature of learning within a community of practice.
Related Concept Videos
01:27Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:21Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K